Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Feb 26, 2024
Open Peer Review Period: Mar 1, 2024 - Apr 26, 2024
Date Accepted: Sep 13, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

German Version of the Telehealth Usability Questionnaire and Derived Short Questionnaires for Usability and Perceived Usefulness in Health Care Assessment in Telehealth and Digital Therapeutics: Instrument Validation Study

Zimmermann J, Morf H, Scharf F, Knitza J, Moeller H, Muehlensiepen F, Nathrath M, Orlemann T, Voelker T, Deckers M

German Version of the Telehealth Usability Questionnaire and Derived Short Questionnaires for Usability and Perceived Usefulness in Health Care Assessment in Telehealth and Digital Therapeutics: Instrument Validation Study

JMIR Hum Factors 2024;11:e57771

DOI: 10.2196/57771

PMID: 39571151

PMCID: 11621722

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

The German version of the Telehealth Usability Questionnaire (TUQ) and derived short questionnaires for usability and healthcare utility assessment in telehealth and digital therapeutics.

  • Jannik Zimmermann; 
  • Harriet Morf; 
  • Florian Scharf; 
  • Johannes Knitza; 
  • Heidi Moeller; 
  • Felix Muehlensiepen; 
  • Michaela Nathrath; 
  • Till Orlemann; 
  • Thomas Voelker; 
  • Merlin Deckers

ABSTRACT

Background:

The exponential growth of telehealth is revolutionizing healthcare delivery, but its evaluation has not matched the pace of its uptake. Various forms of assessment, from single-item to more-extensive questionnaires, have been used to assess telehealth and digital therapeutics and their usability. The most-frequently used questionnaire is the “Telehealth Usability Questionnaire” (TUQ). The use of the TUQ is limited by its restricted availability in languages other than English and its feasibility.

Objective:

The aims of this study were to create a translated German TUQ version and a derived short questionnaire for patients: “Telehealth Usability and Utility Short Questionnaire for patients” (TUUSQ).

Methods:

As a first step, the original 21-item TUQ was forward- and back-translated twice. In the second step, 13 TUQ items were selected for their suitability for general evaluation of telehealth on the basis of expert opinion. These 13 items were surveyed in four studies evaluating 13 healthcare applications including digital therapeutics and a telehealth system (n1 = 129; n2 = 220; n3 = 30; n4 = 12). Psychometric exploratory factor analysis was conducted.

Results:

The analysis revealed that a parsimonious factor structure with two factors (“healthcare utility” and “usability”) is sufficient to describe the patient’s perception. Consequently, the questionnaire could be shortened to six items without compromising its informativeness.

Conclusions:

We provide a linguistically precise German version of the TUQ for assessing the usability and utility of telehealth. Beyond that, we supply a highly feasible short version that is versatile for general use in telehealth, mobile Health and digital therapeutics and which distinguishes between the two factors “healthcare utility” and “usability” in patients. Clinical Trial: No Trial Registration was necessary.


 Citation

Please cite as:

Zimmermann J, Morf H, Scharf F, Knitza J, Moeller H, Muehlensiepen F, Nathrath M, Orlemann T, Voelker T, Deckers M

German Version of the Telehealth Usability Questionnaire and Derived Short Questionnaires for Usability and Perceived Usefulness in Health Care Assessment in Telehealth and Digital Therapeutics: Instrument Validation Study

JMIR Hum Factors 2024;11:e57771

DOI: 10.2196/57771

PMID: 39571151

PMCID: 11621722

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.